Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Engineered Vasculogenic Extracellular Vesicles Drive Nonviral Direct Conversions of Human Dermal Fibroblasts into Induced Endothelial Cells and Improve Wound Closure.

Autor: Rincon‐Benavides, Maria A., Mendonca, Natalia Claire, Cuellar‐Gaviria, Tatiana Z., Salazar‐Puerta, Ana I., Ortega‐Pineda, Lilibeth, Blackstone, Britani N., Deng, Binbin, McComb, David W, Gallego‐Perez, Daniel, Powell, Heather M., Higuita‐Castro, Natalia

Publikováno v: Advanced Therapeutics; Mar2023, Vol. 6 Issue 3, p1-13, 13p

An inducible RIPK3-driven necroptotic system enhances cancer cell-based immunotherapy and ensures safety.

Autor: Chen KS; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Manoury-Battais S; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Kanaya N; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Vogiatzi I; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Borges P; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Kruize SJ; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Chen YC; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Lin LY; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Rossignoli F; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Mendonca NC; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America., Shah K; Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, United States of America.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Nov 19. Date of Electronic Publication: 2024 Nov 19.